Liver transplants without blood type matching: a new hope?
NCT ID NCT07273448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 people who received a liver transplant from a living donor with a different blood type. Researchers will track how long patients survive and how often their body rejects the new liver. The goal is to understand risks and improve care for these transplants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABO-incompatible living donor liver transplantation
- What this could lead to
- If successful, this could help expand the donor pool for liver transplants, making more organs available to patients regardless of blood type.
- What could go wrong
- This is an observational study with only 100 participants, so results may not apply to all patients. There are known risks of rejection and complications after any transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABO INCOMPATIBILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?
- Can a wearable glucose sensor be trusted in the ICU? new study aims to find out
- Liver transplant bleeding study pulled before starting
- New device could keep donor livers healthier before transplant
- Online prehab program aims to boost strength in liver transplant patients
- Pre-Surgery carb drink may speed liver transplant recovery